Prof. Dr. Mekahli Djalila
Special awards or recognition:
2021 ESPN Research Grant. Evaluation of the glucose metabolism in early Autosomal Dominant Polycystic Kidney Disease: a multicentric study.
2018 – 2020 Promotor VLAIO Innovatiemandaat (PostDoc Jean-Paul Decuypere) in collaboration with Galapagos. HBC.2018.2083. Molecular profiling of early stage autosomal dominant polycystic kidney disease (ADPKD) cellular models for drug development.
2019-2023 Co-Promotor Foundation of Scientific Research Flanders (FWO) project: G0C8920N. Ca2+ signalling in ADPKD: mechanisms and consequences.
2017 - 2019 Promotor VLAIO project with Galapagos. HBC.2016.0836 "Research activities to bring new therapeutic options forward for the treatment of patients with Autosomal Dominant polycystic Kidney Disease (ADPKD).
2015 Funding from “UZ Leuven Future Fonds” Visit to initiate a collaboration with “Yale University”.
2012 -2016 Copromotor FWO project. “The role of Ca2+ signaling for cyst formation in autosomal dominant polycystic kidney disease”
2014-2017 Post-doctoral clinical Research fonds (KOF). University hospitals Leuven.
2012-2014 FWO Clinical PhD fellowship (Fund for Scientific Research, Flanders).
2011 Two Best Poster Presentation Awards at the 44th Annual Scientific Meeting of the European Society for Pediatric Nephrology, Dubrovnik – Croatia.
2011 Poster Award at the FASEB meeting Polycystic kidney disease from molecular mechanisms to therapy. Vermont, USA.
2008 Laureate of the Pfizer Educational Grant for promising young physicians. KU Leuven Promotion 2008